|
Real-time Estimate
Cboe BZX
05:15:40 30/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 2.730 USD | +6.64% |
|
-1.45% | +91.55% |
| 16/10 | Edesa Biotech, Inc. Receives FDA IND Clearance For Phase 2 Clinical Study Of EB06 In Vitiligo | CI |
| 20/08 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EDSA | Delayed | |
CBOE
| EDSA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 3.25 | 5.75 | 17.59 |
| Spread/Res. | -16.31% | -52.70% | -84.54% |
| Spread/Supp. | +30.14% | +142.86% | +240.00% |
| Support | 2.09 | 1.12 | 0.8 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EDSA Stock
- Charts Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
